机译:BRAF Paradox断路器PLX8394,PLX7904与BRAFV600E CRC细胞更有效,与BRAF抑制剂PLX4720相比并通过详细的途径分析所示
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
Natl Hellen Res Fdn Inst Chem Biol 48 Vas Constantinou Athens 11635 Greece;
BRAF paradox breakers; Colorectal cancer; RNA-sequencing; Bioinformatics; Combinatorial treatments; Mcl-1 inhibitors; Notch modulators;
机译:PLX8394是新一代BRAF抑制剂,可选择性抑制结肠腺癌细胞中的BRAF并防止反常的MAPK途径活化
机译:BRAF抑制剂PLX4720抑制BRAFV600E突变和正常甲状腺细胞中CXCL8的分泌:BRAF抑制剂的进一步抗癌作用
机译:CYP24A1衰减限制了BRAF(V600E)的进展 - 诱导乳头状甲状腺癌细胞,并使它们敏化至BRAF(V600E)抑制剂PLX4720
机译:对BRAF抑制剂PLX-4720的抗性导致BRAFV600E阳性黑素瘤细胞系中的戏剧性EGFR基因表达变化
机译:PLX8394是新一代BRAF抑制剂可选择性抑制结肠腺癌细胞中的BRAF并阻止反常的MAPK途径活化
机译:PLX8394是一种新一代BRAF抑制剂,选择性地抑制结肠腺癌细胞中的BRAF,并防止矛盾的MAPK途径激活